Publication Name	World Journal of Gastroenterology
Manuscript ID	17146
Country	Japan

Received	2015-02-21 19:04
Peer-Review Started	2015-02-22 21:32
To Make the First Decision	2015-04-13 14:35
Return for Revision	2015-04-15 18:53
Revised	2015-04-27 09:08
Second Decision	2015-05-04 08:26
Accepted by Journal Editor-in-Chief	2015-05-05 00:28
Accepted by Company Editor-in-Chief	2015-05-07 16:04
Articles in Press	2015-05-07 16:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-06-15 11:29
Publish the Manuscript Online	2015-06-29 16:33

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Review
Article Title	Liver fibrosis markers of nonalcoholic steatohepatitis
Manuscript Source	Invited Manuscript
All Author List	Hirayuki Enomoto, Yukihiro Bando, Hideji Nakamura, Shuhei Nishiguchi and Masafumi Koga
Funding Agency and Grant Number
Corresponding Author	Masafumi Koga, MD, PhD, Department of Internal Medicine, Kawanishi City Hospital, Kawanishi, Hyogo 664-8533, Japan. m-koga@kawanishi-city-hospital.com
Key Words	Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver fibrosis; Glycated albumin; Glycated hemoglobin
Core Tip	Due to the increasing prevalence of obesity and diabetes, nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases. In particular, nonalcoholic steatohepatitis (NASH), a subgroup of NAFLD, has become a major health concern. A liver biopsy remains the gold standard method for the accurate diagnosis of NASH and the evaluation of the degree of liver fibrosis. However, due to the limitations associated with the performance of liver biopsies, noninvasive biomarkers have been proposed to estimate the degree of liver fibrosis. Recently, new approaches based on glycated proteins have been developed, and these methods may help to improve the management of NAFLD/NASH.
Publish Date	2015-06-29 16:33
Citation	Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(24): 7427-7435
URL	http://www.wjgnet.com/1007-9327/full/v21/i24/7427.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i24.7427

Full Article (PDF)	WJG-21-7427.pdf
Full Article (Word)	WJG-21-7427.doc
Manuscript File	17146-Review.docx
Answering Reviewers	17146-Answering reviewers.pdf
Audio Core Tip	17146-Audio core tip.wma
Conflict-of-Interest Disclosure Form	17146-Conflict-of-interest statement.pdf
Copyright License Agreement	17146-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	17146-Language certificate.pdf
Peer-review Report	17146-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	17146-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	17146-Scientific misconduct check.pdf
Scientific Editor Work List	17146-Scientific editor work list.pdf